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Background
Bulky DNA adducts are markers of exposure to genotoxic aromatic compounds and of the ability of the individual to metabolically activate carcinogens and to repair DNA damage (1). Experimental studies in animal models have highlighted the central role of DNA adduct formation in tumorigenesis (2), and key human studies have shown that carcinogenic polycyclic aromatic hydrocarbons (PAHs) represent a major class of carcinogens present in the environment, that are capable of forming DNA adducts at the same DNA bases where p53 mutations are found in lung cells of smokers (3). When unrepaired, DNA adducts can cause mutations, including mutational hot-spots in the p53 tumour suppressor gene and other genes, that may ultimately induce cancer formation (3) .
Human studies have shown a dose-response relationship between occupational exposure to PAHs and the levels of DNA adducts in lymphocytes of workers (4), but at high levels of exposure saturation seems to occur. Although cigarette smoke also contains PAHs and other DNA adductforming compounds, studies on the association between tobacco smoking and DNA adducts in white blood cells (WBC) have yielded inconsistent results (5). In contrast, studies conducted on human lung tissue did show an association with tobacco smoke (4-7). Some studies have reported a negative correlation between DNA adduct levels and the consumption of fruit and vegetables and the intake of flavonoids (8) (9) (10) (11) , and the dose response-relationship with smoking may be affected by various dietary factors, especially in subjects with certain genetic polymorphisms in metabolic enzymes (5). Other factors that were reported to influence DNA adduct formation included: body mass index (BMI), genetic polymorphisms in genes involved in the metabolism of carcinogens, the season in which the WBC/lymphocytes were sampled, and environmental pollutants such as O 3 and particulate matter (PM) (4, 6, (12) (13) (14) . A study undertaken in New York City after the events of 11
September 2001 found a direct relationship between the amount of DNA adducts in umbilical cord Seasonality in DNA adduct levels has been observed and may be linked to the variability in air quality and human behaviour determining exposure between, for instance, summer and winter.
The same variability with season could also be attributable to dietary habits. It is still insufficiently clear which factors contribute to the large inter-individual variation in DNA adduct levels that is observed, even when people are apparently exposed to similar doses of genotoxins.
Therefore, we have conducted a large pooled analysis in healthy individuals (∼3,600 subjects) recruited in the context of case-control, cross-sectional or cohort studies, with the purpose of validating or refuting previous findings in a sufficiently powered dataset (8, 9, 11, 12, (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) .
Methods
We have identified eleven study cohorts, investigated in 18 publications, listed in Table 1 , in which bulky DNA adducts were measured by 32 P-postlabelling (Phillips et al. 2007) , and a similar set of variables was available including individual data on age, gender, ethnicity, batch, smoking habits, BMI, season of blood collection and a limited set of gene variants. We contacted the principal investigators of these studies and had access to the original data sets. The study characteristics are briefly described in Table 1 .
In most of the studies measurement of bulky adducts by 32 P-postlabelling was achieved using the nuclease P1 digestion method of enrichment, although butanol extraction was used in the study of Bak and coworkers (2006) . In each investigation, subjects were enrolled after signing informed consent. Data sets were transferred to the ISI Foundation for analysis after being anonymized.
There were some differences in the mean levels of adducts among the studies, with the US study showing the highest values (23, 24) . This is most likely due to inter-laboratory differences where RAL = relative adduct labelling; Mean ic and SD ic = mean and standard deviation of the group of subjects in the i th study. The rationale for using normalized values and quartiles to standardize genetic pooled analysis has been put forward previously by several authors and this approach has become common practice (4, (30) (31) (32) . Since after standardization the skewness of the distribution of RALst was still high (>2.9), we compared standardized values of adduct levels using the non parametric Kruskal-Wallis test; (b) we repeated all the statistical analyses excluding the study from the US in which DNA adduct data were on average 8-fold higher than in the other studies (see Table 2 ); (c) for those studies in which DNA adduct analyses were performed in different laboratories but using samples from the same populations (EPIC SPAIN and GENAIR in Spanish populations and TURIN bladder case control study, EPIC ITALY and GENAIR in Italian populations), we have applied analysis-of-variance (ANOVA) to compare the area effect with the laboratory effect.
In addition to descriptive statistics and ANOVA we have performed univariate analyses and multivariate regression models stratified by smoking habits, excluding those studies in which blood samples were not collected in all seasons (GREECE, CZECH REPUBLIC and EAST EUROPE studies). In the multivariate model we included sex, age and seasonality. To control for heterogeneity among studies we also performed multivariate regression models including the variable "study" as having a random effect. Finally, we performed a logistic regression analysis in All statistical analyses were performed using SAS software (v.9.1.3). Table 2 shows the mean adduct levels, and standard deviations, for the studies that were included in the analysis. There are relatively small variations among the studies except for the US cohort that has adduct levels about a factor 8 higher than others. For this reason in the subsequent analyses we use normalized levels. No statistically significant difference in DNA adduct levels with gender and body mass index was observed (Table 3) . Age showed a borderline significant association (p=0.09), although no clear trend was observed. Seasonality (i.e. the season in which blood was drawn) and smoking (with higher levels in never smokers) were significantly associated with DNA adducts, p=0.006 and 0.0003, respectively. Among the genetic variants that were analyzed in these studies, no statistically significant difference in DNA adduct levels with the variant genotypes was found (Table 4) .
Results
To verify if the finding on smoking is true and not an artificial effect due to the statistical correction we stratified the analysis between studies in which DNA adducts were measured in WBC and studies in which they were measured in lymphocytes and we obtained the same trend as in the global analysis.
In the stratified multivariate analysis (Table 5) , we observed an effect of seasonality in nonsmokers, with the lowest levels in the spring (p=0.02), and an effect of sex, with women having higher levels, among current smokers (p=0.01). France and Greece), with a p-value for the difference of 0.001.
Discussion
PAHs are an important class of environmental carcinogens, capable of inducing DNA adducts after metabolic activation (33). PAHs may occur in fried and charcoal-grilled meat or in the food chain as a result of environmental pollution (34-36). As a result, human exposure to PAHs is widespread and may occur via inhalation, ingestion or via dermal contact. The latter seems less relevant for the general population, but may be of relevance in certain groups such as in occupational settings or after treatment with coal-tar ointments. These exposures are thought to contribute to cancer incidence in the general population, since the most important targets for PAH carcinogenicity include lung and possibly bladder (1) . Some evidence has also been reported for an association between dietary PAHs and colon cancer or adenomas (37, 38 The present study is the largest pooled analysis available on bulky DNA adducts (∼3,600 subjects), and shows only weak associations. The analysis restricted to studies having data for every season confirms an association with the season at the time of blood collection, as suggested in previous smaller studies. In non-smokers we found significantly lower DNA adduct levels in spring (p=0.02) than in winter, with a seasonal gradient similar to the one shown for median levels in Table 3 . This may have two alternative explanations: the first is a protective effect of seasonal dietary intakes such as fresh fruit and vegetables, although this is less likely to peak in the spring, when the lowest RAL were observed. Such a protection has been suggested in previous investigations (8-11), but could not be tested directly in the current analysis, because the datasets are too heterogeneous in the way dietary data were collected. The second potential explanation is a higher level of bulky adducts in some seasons due to higher levels of exposure to pollution, particularly to particulate-bound
PAHs. This can be due to seasonal differences in emissions, weather conditions and/or outdoor human activity. This hypothesis seems to be supported by some of the previous investigations (33), and is confirmed by a comparison among the areas for which we had adduct measures from different laboratories. In fact, after adjusting for the laboratory effect and cell type, mean adduct Recently it has been demonstrated that phase II enzymes can be induced by PAHs found in cigarette smoke (49). These enzymes are involved in the process of detoxification of numerous carcinogens such as PAHs and aryl-and heterocyclic amines (50), and their induction by tobacco smoke could be an alternative explanation for the smoking effect in our study, where preferential induction of phase II enzymes can lead to more rapid clearance of PAHs prior to adduct formation.
Moreover inter-individual differences exist in the levels of expression and catalytic activities of a variety of xenobiotic-metabolizing enzymes in humans and these phenomena are thought to be critical in understanding the basis of different susceptibilities of individuals to PAH action (51). 
